Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer

PURPOSE: RTOG 0617 compared standard-dose (SD; 60 Gy) versus high-dose (HD; 74 Gy) radiation with concurrent chemotherapy and determined the efficacy of cetuximab for stage III non–small-cell lung cancer (NSCLC). METHODS: The study used a 2 × 2 factorial design with radiation dose as 1 factor and ce...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Oncol
Main Authors: Bradley, Jeffrey D., Hu, Chen, Komaki, Ritsuko R., Masters, Gregory A., Blumenschein, George R., Schild, Steven E., Bogart, Jeffrey A., Forster, Kenneth M., Magliocco, Anthony M., Kavadi, Vivek S., Narayan, Samir, Iyengar, Puneeth, Robinson, Clifford G., Wynn, Raymond B., Koprowski, Christopher D., Olson, Michael R., Meng, Joanne, Paulus, Rebecca, Curran, Walter J., Choy, Hak
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Clinical Oncology 2020
Fag:
ORIGINAL REPORTS
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048161/
https://ncbi.nlm.nih.gov/pubmed/31841363
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01162
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker